Law School symposium examines life, service of renowned Judge Nathaniel Jones
In recognition of Judge Nathanial Jones and his remarkable service to the United States and its citizens, the University of Cincinnati Law Review will host the symposium Answering the Call: The Social Justice Life of the Honorable Nathaniel Raphael Jones. The event will be held Thurs., Nov. 5 at 12:15 p.m. via WebEx. CLE: Application pending for 1.0 CLE in OH and KY.
About the symposium
The symposium will examine Judge Jones’ life and service to our country, including his service as the United States attorney for the Northern District of Ohio, his pioneering work as the NAACP legal counsel and his remarkable service as a federal judge on the U.S. Sixth Circuit Court of Appeals. His tremendous contributions influenced attorneys not only in the United States but also across the world.
Answering the Call will feature the well-known legal scholars and practitioners:
- Dennis Parker, CEO of the National Center for Law and Economic Justice;
- Elise Boddie, Henry Rutgers Professor, Robert L. Carter Scholar, Rutgers Law School;
- Erika Wilson, Associate Professor of Law, Wade Edwards Distinguished Scholar, Thomas Willis Lambeth Distinguished Chair in Public Policy, and Director of Clinical Programs, University of North Carolina School of Law; and
- Renee Hutchins, Dean and Professor of Law, University of the District of Columbia David A. Clarke School of Law.
All the speakers will address a range of topics representative of the significant breadth and scope of Judge Jones’ work and achievements. The speakers will also address diversity on the federal courts as well as the current state of the judicial appointments process.
Tags
Related Stories
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.
Weight loss drugs help, but not on their own
January 5, 2026
Millions of Americans are on one type of weight loss drug or another, and a University of Cincinnati physician says there are things to know as we enter the new year. Malti Vij, MD, adjunct associate professor in the Department of Internal Medicine and provider at UC Health Primary Care in Mason, recently spoke to 91.7 WVXU News.